Latest Form 4 insider transactions

Richard Dean Bingham, a Director of Midland States Bancorp, Inc., received 341 shares of common stock on September 30, 2026.

Jeffrey M Mcdonnell, a Director of Midland States Bancorp, Inc., received 282 shares of common stock on September 30, 2026.

Japan Post Holdings Co., Ltd. reported changes in beneficial ownership of Aflac Inc common stock on September 29, 2026.

Richard T Ramos, a Director of Midland States Bancorp, Inc., received 514 shares of common stock on September 30, 2026.

Ronald Brown, PRESIDENT and a Director of New England Realty Associates Limited Partnership, reported multiple transactions in common stock on September 30, 2026.

Jerry L. Mcdaniel, a Director of Midland States Bancorp, Inc., received 396 shares of common stock on September 30, 2026.

Robert F. Schultz, a Director of Midland States Bancorp, Inc., reported multiple transactions in common stock on September 30, 2026.

Eyal Talor, Chief Scientific Officer of Cel Sci Corp, received 1,165 shares of common stock on September 30, 2026.

Patricia B Prichep, Chief Financial Officer of Cel Sci Corp, received 2,082 shares of common stock on September 30, 2026.

Geert R Kersten, Chief Executive Officer and a Director of Cel Sci Corp, received 2,621 shares of common stock on September 30, 2026.

John E Kiernan, President and CEO and a Director of Alico, Inc., reported multiple transactions in common stock on October 1, 2026.

Es-Johansson An Van, a Director of Plus Therapeutics, Inc., reported multiple transactions in common stock on October 1, 2026.

Richard J Hawkins, a Director of Plus Therapeutics, Inc., reported multiple transactions in common stock on October 1, 2026.

Andrew John Hugh Macintyre Sims, Chief Financial Officer of Plus Therapeutics, Inc., reported multiple transactions in common stock on October 1, 2026.

Howard Clowes, a Director of Plus Therapeutics, Inc., reported multiple transactions in common stock on October 1, 2026.

Marc H Hedrick, Chief Executive Officer and a Director of Plus Therapeutics, Inc., reported multiple transactions in common stock on October 1, 2026.

Ronald Asbury Andrews, a Director of Plus Therapeutics, Inc., reported multiple transactions in common stock on October 1, 2026.

Kyle Guse, a Director of Plus Therapeutics, Inc., reported multiple transactions in common stock on October 1, 2026.

Armada Acquisition Corp. II shareholders have overwhelmingly approved all proposals related to the business combination with Evernorth Holdings Inc., paving the way for the transaction.

Richard Barry, President & CEO and a Director of Cassava Sciences Inc, purchased 306,813 shares of common stock on September 29, 2026.

Kun Dai, Chief Executive Officer and a Director of Uxin Ltd, purchased 7,443 shares of common stock on September 30, 2026 for $1.34 per share.

Konstantinos Konstantakopoulos, Chairman and CEO and a Director of Costamare Inc., reported a transaction in 74,800 shares of common stock on September 30, 2026.

Agility Robotics and FORT Robotics have formalized a strategic partnership to enhance the safety architecture of Agility's next-generation humanoid robot, Digit 5.

Milton C Ault Iii and 1 other reported changes in beneficial ownership of Hyperscale Data, Inc. common stock on September 29, 2026.

Yanjun Wang, CCO and GC of Sea Ltd, sold 2,000 shares of common stock on September 29, 2026.

Grafiti Group LLC and 1 other reported changes in beneficial ownership of Game Your Game Inc. common stock on September 28, 2026.

Michael Ho, Chief Strategy Officer and a Director of Hut 8 Corp., reported a transaction in 1,500,000 shares of common stock on September 29, 2026.

Larry G Swets Jr, a Director of Greenland Energy Co, reported multiple transactions in common stock on September 28, 2026.

Hassan Baqar, a Director of Greenland Energy Co, reported a transaction in 75,000 shares of common stock on September 28, 2026.

Cobian Mauricio Doehner, EVP Corporate Affairs of Cemex Sab De Cv, sold 927,900 shares of common stock on September 30, 2026 for $9.57 per share.